(Sharecast News) - Digital health company Trellus Health announced a significant agreement with a major US health plan on Wednesday, targeting inflammatory bowel disease (IBD) management.
The AIM-traded firm said that under the terms of the agreement, spanning up to 21 months, eligible members of the health plan residing in two US states would gain access to Trellus Health's 'Elevate' IBD programme.
It said the programme aimed to enhance outcomes and reduce costs associated with IBD care through digital health interventions.
Trellus Health said its Elevate IBD programme leverages scientifically-validated methodologies to address the complex interplay between physical and mental health in chronic conditions like IBD.
By prioritising holistic care, the programme looked to improve patient well-being while containing healthcare expenditure.
At 1256 GMT, shares in Trellus Health were down 6.67% at 3.5p.
Reporting by Josh White for Sharecast.com.
Trellus Health. (TRLS)